Treatment course and outcomes of neovascular age-related macular degeneration in patients receiving intraocular pressure-lowering drops

Related

• 

  Expert Panel: Faricimab and Aflibercept 8 mg in AMD

  John T. Thompson, MD

  Andrew A. Moshfeghi, MD, MBA, FASRS

  Manjot K Gill, MD, FASRS

  Christina Y Weng, MD, MBA, FASRS

  Ferhina S Ali, MD, MPH

  Ian Pearce, MB ChB BSc FRCOPHTH

  Annual Meeting Talks

  2024

• 

  Association Between Provider Anti-VEGF Injection Rates and Visual Outcome In Eyes With Neovascular Age-Related Macular Degeneration

  Michael M. Lai, MD, PhD

  Annual Meeting Talks

  2024

• 

  Wet AMD 5 Symposium

  Annual Meeting Talks

  2020